GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Rep. Jake Auchincloss Questions FDA’s National Priority Voucher Program Over Lack of Congressional Approval and Transparency

by GOAI
Share To

Rep. Jake Auchincloss of Massachusetts has raised concerns regarding the FDA’s Commissioner’s National Priority Voucher program, stating that it lacks congressional approval. In addition, Auchincloss pointed out that the FDA has yet to disclose information about eight senior reviewers involved in the program.

The comments from Rep. Auchincloss highlight transparency issues surrounding the voucher initiative, which aims to prioritize certain regulatory reviews. He criticized the absence of legislative endorsement for the program and noted a lack of public disclosure regarding key personnel overseeing its implementation. The FDA has not responded publicly to these claims or provided further clarification on the matter.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Shriners Children’s Launches Multi-Center Study on Fractional CO2 Laser Technology for Pediatric Burn Care
2026-02-11
Rising Lung Cancer Cases Among Non-Smokers Linked to Genetic and Environmental Factors
2026-02-11
Path Planning Transformer Introduced to Enhance Multi-Robot Navigation in Complex Environments
2026-02-11
Amrize Corporation Appoints Three New Directors Following Departure of James Carter and Linda Nguyen
2026-02-11
Xilio Therapeutics Prices Public Offering of 12 Million Shares at $3 Each
2026-02-11
Study Maps Cellular and Molecular Changes in Pancreatic Tissue During Type 1 Diabetes Progression
2026-02-11
Applied Materials Resolves U.S. Export Control Investigation with Financial Penalty and Compliance Measures
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top